PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

The stock's fall snapped a two-day winning streak.

A special CBI court, presided over by Judge Rakesh Gupta, has sentenced two Punjab Police officials—formerSHO Gurbhinder ...

Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

Punjab Agricultural University (PAU) is set to launch India's first Artificial Intelligence (AI) school within its campus, ...

PTC Industries inks aerospace MoU with Odisha government, sparking a nearly 5% rally in the company’s stock price.

One of the top advanced manufacturing and material technology companies, PTC Industries, has inked a Memorandum of ...

PTC automatically controls train speeds when needed, reducing the risk of train collisions and preventing human error, while ...

Shares of PTC Inc. PTC advanced 1.30% to $190.93 Tuesday, on what proved to be an all-around great trading session for the ...